In vitro diffusion testing per EMA guideline

In vitro permeation testing

We proudly present Teledyne Hanson’s Phoenix™ Dry-Heat Diffusion Systems: a new benchmark in in vitro diffusion testing. Designed for precision, scalability, and compliance with international standards, these systems are ideally suited for IVRT and IVPT workflows as outlined by both the EMA guideline and FDA guidance. The Phoenix platform includes:

Scientific foundation and regulatory relevance

In vitro diffusion testing plays a vital role in the evaluation of topical and transdermal pharmaceutical products. These models provide a reliable and ethically sound method to assess in vitro release testing (IVRT) and in vitro permeation testing across synthetic membranes or biological barriers like human or animal skin.

Both the European Medicines Agency (EMA) and the U.S. FDA recognize the relevance of standardized in vitro methods for establishing bioequivalence, especially when clinical trials are impractical or ethically challenging. The EMA guideline on the quality and equivalence of topical products highlights IVRT and IVPT as key tools in product development and regulatory approval.

In Vitro Release Testing (IVRT)

This method focuses on the release rate and quantity of active pharmaceutical ingredients (APIs) from a semi-solid formulation, typically into a synthetic membrane or hydrophilic receptor medium. It is especially useful for creams, gels, ointments, and other semi-solid dosage forms. The method supports:

  • Batch-to-batch consistency verification
  • Stability studies
  • Quality control of formulations


The
Phoenix Diffusion Cells and Phoenix DB-6 system offer precise temperature control and ease of sampling, enabling high-fidelity IVRT results in line with EMA guidelines.

In Vitro Permeation Testing (IVPT)

This method goes one step further by assessing the actual absorption of the API through excised skin tissue. It’s an indispensable technique for understanding dermal drug delivery and establishing therapeutic equivalence for locally acting formulations.

The Phoenix RDS Automated Diffusion System, with capacity for up to 24 cells, ensures robust and scalable IVPT workflows. It supports time-dependent permeation profiling with:

  • Controlled temperature and stirring
  • Automated, repeatable sampling
  • High-throughput setup for comparative studies


This method is commonly applied in the development of topical corticosteroids, NSAIDs, antifungals, and cosmetic actives.

Phoenix-cell-with-callouts

Validation and instrumentation

Both must comply with ICH Q2(R1) guidelines on method validation. Essential parameters include:

  • Specificity
  • Linearity
  • Accuracy and precision
  • Robustness and reproducibility


Teledyne Hanson’s
Phoenix DB-6 and RDS systems meet these demands through:

  • Reproducible dry-heat control
  • Seamless integration with standard diffusion cells
  • Compatibility with validated analytical workflows

Future-proof your diffusion-cell testing

Whether you’re conducting product development, quality control, or regulatory submission testing, in vitro diffusion testing provides critical insights into product performance. By aligning your processes with EMA and FDA guidelines, you ensure the reliability and credibility of your data.

Teledyne Hanson’s Phoenix™ systems combine scientific rigor with operational efficiency, making them the preferred choice for pharmaceutical and cosmetic laboratories worldwide.

Elevate your diffusion-cell testing experience with our cutting-edge solutions.

Contact us to learn more about our advanced solutions for diffusion testing, method validation, and regulatory support.